These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36505442)

  • 21. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity.
    Falck-Jones S; Österberg B; Smed-Sörensen A
    J Intern Med; 2023 Feb; 293(2):130-143. PubMed ID: 35996885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
    Kared H; Redd AD; Bloch EM; Bonny TS; Sumatoh H; Kairi F; Carbajo D; Abel B; Newell EW; Bettinotti MP; Benner SE; Patel EU; Littlefield K; Laeyendecker O; Shoham S; Sullivan D; Casadevall A; Pekosz A; Nardin A; Fehlings M; Tobian AA; Quinn TC
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33427749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8
    Mortezaee K; Majidpoor J
    Front Immunol; 2022; 13():864298. PubMed ID: 35432340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives.
    Zhu Q; Xu Y; Wang T; Xie F
    Front Immunol; 2022; 13():1053437. PubMed ID: 36505489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique immunological profile in patients with COVID-19.
    Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
    Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations.
    Habel JR; Chua BY; Kedzierski L; Selva KJ; Damelang T; Haycroft ER; Nguyen TH; Koay HF; Nicholson S; McQuilten HA; Jia X; Allen LF; Hensen L; Zhang W; van de Sandt CE; Neil JA; Pragastis K; Lau JS; Jumarang J; Allen EK; Amanant F; Krammer F; Wragg KM; Juno JA; Wheatley AK; Tan HX; Pell G; Walker S; Audsley J; Reynaldi A; Thevarajan I; Denholm JT; Subbarao K; Davenport MP; Hogarth PM; Godfrey DI; Cheng AC; Tong SY; Bond K; Williamson DA; McMahon JH; Thomas PG; Pannaraj PS; James F; Holmes NE; Smibert OC; Trubiano JA; Gordon CL; Chung AW; Whitehead CL; Kent SJ; Lappas M; Rowntree LC; Kedzierska K
    JCI Insight; 2023 Apr; 8(7):. PubMed ID: 37036008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection.
    Anindya R; Rutter GA; Meur G
    Immunol Cell Biol; 2023 Mar; 101(3):191-203. PubMed ID: 36529987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune modulation as a consequence of SARS-CoV-2 infection.
    Gelmez MY; Oktelik FB; Tahrali I; Yilmaz V; Kucuksezer UC; Akdeniz N; Cetin EA; Kose M; Cinar C; Oguz FS; Besisik S; Koksalan K; Ozdemir O; Senkal N; Gul A; Tuzun E; Deniz G
    Front Immunol; 2022; 13():954391. PubMed ID: 36110850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological features of coronavirus disease 2019 in patients with cancer.
    Thibaudin M; Fumet JD; Bon M; Hampe L; Limagne E; Ghiringhelli F
    Eur J Cancer; 2020 Nov; 139():70-80. PubMed ID: 32977223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
    J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.
    Jiménez-Cortegana C; Liró J; Palazón-Carrión N; Salamanca E; Sojo-Dorado J; de la Cruz-Merino L; Pascual Á; Rodríguez-Baño J; Sánchez-Margalet V
    Viral Immunol; 2021 Nov; 34(9):639-645. PubMed ID: 34529510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
    Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
    Front Immunol; 2022; 13():817905. PubMed ID: 35185909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.
    Goletti D; Petrone L; Manissero D; Bertoletti A; Rao S; Ndunda N; Sette A; Nikolayevskyy V
    Clin Microbiol Infect; 2021 Dec; 27(12):1784-1789. PubMed ID: 34256141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
    Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
    Front Immunol; 2021; 12():697622. PubMed ID: 34777333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women.
    Hsieh LE; Grifoni A; Dave H; Wang J; Johnson D; Zellner J; Sidney J; Chambers C; Franco A
    J Reprod Immunol; 2022 Feb; 149():103464. PubMed ID: 34953325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity.
    Mi Y; Liang L; Xu K; Li Q; Wang W; Dang W; Deng J; Zhi Y; Li X; Tan J
    Front Cell Infect Microbiol; 2022; 12():986350. PubMed ID: 36439228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
    J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.